Effect of adipose tissue-derived mesenchymal stem cells versus melatonin on skeletal muscle of reserpine-induced fibromyalgia in adult male albino rat model: Histological, behavioral, and biochemical studies.
El-Beltagi EM., Abumandour M., El-Harty YM., Shukry M., Abo-Elyazed AAE.
Animal Study on Chronic Inflammation, published in Tissue Cell (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Tissue Cell (2026)
- Country
- Scotland
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42468470
- DOI
- 10.1016/j.tice.2026.103762
Abstract (original English)
Fibromyalgia (FM) is a chronic disorder marked by ongoing musculoskeletal pain and weakness, with only symptomatic treatments available. Reserpine, a natural alkaloid, can cause symptoms resembling FM. Melatonin is a hormone with anti-inflammatory and antioxidant properties. Adipose tissue-derived mesenchymal stem cells (AD-MSCs) represent a novel approach for treating various diseases. This experimental study aimed to assess and compare the therapeutic capacity of melatonin and AD-MSCs in alleviating reserpine-induced FM changes in rats. Eighty adult male albino rats were categorized equally into four groups: control group I; group II, which was subcutaneously injected with reserpine (1 mg/kg) once daily over the flank for three continuous days to induce FM; group III, which was induced for FM as in group II, then orally received melatonin (5 mg/kg) once daily for four weeks; and group IV, which was induced for FM as in group II, then IV injected once by AD-MSCs (1 ×10 6 /rat). Behavioral tests were performed to assess motor, pain, and depressive-related behaviours. Blood and gastrocnemius muscle specimens were collected for biochemical, histological, morphometric, ultrastructural, and statistical studies. Group II exhibited marked deterioration in the behavioral and biochemical profile and enormous structural changes, including splitting of muscle fibers and sarcoplasmic loss
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level ASystematic ReviewEurope PMC
Exosomes as Cellular Communicators and Therapeutic Agents in Orthopedic Diseases: From Mechanisms to Intervention
Systematic Review on Osteoarthritis, Chronic Inflammation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine1 citations - Level ASystematic ReviewEurope PMC
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review
Systematic Review on Chronic Inflammation, Immune Modulation, published in Front Oncol (2026) — summary generated from the PubMed abstract.
- 2026
Front Oncol - Level ASystematic ReviewEurope PMC
Trends in peripheral nerve injury research: a bibliometric analysis focused on molecular mechanisms
Systematic Review on Chronic Inflammation, published in Front Neurol (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurol